Full Stack Software Engineer 1 at Illumina

Cambridge, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Life Sciences, GenomicsIndustries

Requirements

Candidates should have 0-2 years of professional experience in full-stack development, proficiency in TypeScript, Node.js, and Angular, understanding of RESTful API development and microservices, basic knowledge of relational and NoSQL databases like PostgreSQL, MongoDB, or MySQL, familiarity with version control tools like Git, and willingness to learn and adopt best software development practices. Exposure to data visualisation libraries such as D3.js, Chart.js, or similar is a plus, and strong problem-solving skills and attention to detail are required.

Responsibilities

The Full Stack Software Engineer I will assist in developing and maintaining full-stack applications using Angular (frontend) and Node.js (backend), work on RESTful APIs and microservices using TypeScript and Node.js, collaborate with senior engineers to implement scalable and efficient solutions, support database operations with PostgreSQL, MongoDB, or MySQL, develop interactive data visualisations to enhance user insights and decision-making, write clean, maintainable code while adhering to best practices, participate in code reviews and continuous learning, debug and troubleshoot software issues with guidance from senior engineers, and work closely with UI/UX designers to develop user-friendly interfaces.

Skills

TypeScript

Node.js

Angular

Problem-Solving

Communication

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free